# Contact MOTS-c Compound — An Editorial MOTS-c peptide Digest

> Contact MOTS-c Compound, an independent editorial digest of the MOTS-c peptide research literature. Editorial and correction inquiries only — not a clinic or vendor.

Editorial questions, source suggestions, and corrections to the record — we read every note.

## Editorial Inquiries

MOTS-c Compound is an editorial publication, and this form reaches the editorial desk. We welcome corrections, citations we may have missed, and questions about how a finding on this site was sourced. If you believe we have characterized a study incorrectly, tell us — accuracy is the point of the project, and we update the record when the literature warrants it.

Use the form to send a message. Include the page and the specific claim you are writing about where you can; a link to the study you have in mind helps us respond precisely.

## What We Cannot Help With

We are not a clinic and not a vendor, so there are requests we cannot answer. We do not provide medical advice, dosing, or treatment guidance. We do not sell, supply, source, or broker MOTS-c or any other compound, and we cannot recommend pharmacies, clinics, or suppliers. We cannot tell you whether MOTS-c is appropriate for any individual — that is a question for a licensed healthcare professional, not an editorial digest.

For the regulatory picture — what MOTS-c's FDA standing is and how compounded access works in general — the [MOTS-c legal status and 503A category](/legal-status) page collects the cited facts. For everything else about the science, the [frequently asked questions about MOTS-c](/faq) is the fastest route in.

---

An exhibition-wall reading of the mitochondrial-derived MOTS-c peptide literature — each study hung as its own plate and cited, the large search demand held apart from the empty human-trial wall, and the FDA research-only standing and July-2026 PCAC agenda noted before anything else; no clinic curates this room and nothing here is dispensed or sold.